Showing results (41-50 of 262) with videos related to
Sort By:
Pageof 27
Schizophrenia Bulletin|September 19, 2012
Twenty-five years of glutamate in schizophrenia: are we there yet?Daniel C JavittCurrent Opinion in Psychiatry|April 14, 2006
Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patientsDaniel C JavittThe American Journal of Managed Care|September 3, 2014
Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: a clinical overviewDaniel C JavittSchizophrenia Bulletin|October 17, 2009
Sensory processing in schizophrenia: neither simple nor intactDaniel C JavittNovartis Foundation Symposium|May 24, 2008
Phenomenology, aetiology and treatment of schizophreniaDaniel C JavittHandbook of Experimental Pharmacology|October 3, 2012
Glycine transport inhibitors in the treatment of schizophreniaDaniel C JavittAdvances in Neurobiology|November 19, 2024
Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in SchizophreniaDaniel C JavittFrontiers in Psychiatry|February 19, 2021
Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for SchizophreniaPejman Sehatpour, Michael Avissar, Joshua T Kantrowitz, et al.The American Journal of Psychiatry|January 2, 2015
Sensory processing dysfunction in the personal experience and neuronal machinery of schizophreniaDaniel C Javitt, Robert FreedmanBehavioural Brain Research|May 13, 2009
Neurophysiological and neurochemical animal models of schizophrenia: focus on glutamateStephan Bickel, Daniel C JavittPageof 27